Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-16

Clinical Trial Update: Inpatient Penicillin Delabeling for Low-Risk Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update from University of Tennessee evaluating inpatient penicillin delabeling for low-risk patients with penicillin allergy; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Penicillin (penicillin)

Snippet

Sponsor: University of Tennessee | Conditions: Penicillin, Drug Allergy | Phase 4 | Status: ENROLLING_BY_INVITATION